Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Boehringer Ingelheim
McKesson
Baxter
US Department of Justice
Fuji
Mallinckrodt
Accenture
US Army

Generated: February 18, 2019

DrugPatentWatch Database Preview

Allergan Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ALLERGAN INC, and what generic alternatives to ALLERGAN INC drugs are available?

ALLERGAN INC has two approved drugs.

There are nine US patents protecting ALLERGAN INC drugs.

There are forty-seven patent family members on ALLERGAN INC drugs in sixteen countries.

Summary for Allergan Inc
International Patents:47
US Patents:9
Tradenames:2
Ingredients:2
NDAs:2
Drug Master File Entries: 4
Patent Litigation for Allergan Inc: See patent lawsuits for Allergan Inc

Drugs and US Patents for Allergan Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Inc SEYSARA sarecycline hydrochloride TABLET;ORAL 209521-002 Oct 1, 2018 RX Yes No 8,513,223 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Inc SEYSARA sarecycline hydrochloride TABLET;ORAL 209521-003 Oct 1, 2018 RX Yes Yes 8,513,223 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Inc SEYSARA sarecycline hydrochloride TABLET;ORAL 209521-003 Oct 1, 2018 RX Yes Yes 9,481,639 ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Inc RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes 8,883,838 ➤ Try a Free Trial Y ➤ Try a Free Trial
Allergan Inc SEYSARA sarecycline hydrochloride TABLET;ORAL 209521-003 Oct 1, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Allergan Inc SEYSARA sarecycline hydrochloride TABLET;ORAL 209521-001 Oct 1, 2018 RX Yes No 8,318,706 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Allergan Inc SEYSARA sarecycline hydrochloride TABLET;ORAL 209521-001 Oct 1, 2018 RX Yes No 8,513,223 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Farmers Insurance
McKinsey
Cantor Fitzgerald
Merck
Cipla
Medtronic
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.